Journal of International Oncology››2017,Vol. 44››Issue (1): 41-44.doi:10.3760/cma.j.issn.1673-422X.2017.01.011

Previous ArticlesNext Articles

Application of bevacizumab for malignant brain edema

Yu Lan, Zhang Xiaotao, Liu Li, Han Xiaona

  1. Cancer Prevention Center, Second Affiliated Hospital of Qingdao University, Qingdao Central (Cancer) Hospital, Qingdao 266042, China
  • Online:2017-01-08Published:2016-12-07
  • Contact:Zhang Xiaotao, Email: zljyjd@126.com E-mail:zljyjd@126.com

Abstract:Anti-angiogenic drugs such as bevacizumab can effectively alleviate the patients′ brain edema and clinical symptoms and improve the patients′ life quality by reducing vascular permeability and the blood-brain barrier damage. Bevacizumab has got positive efficacy in the clinical, so that it is considered as an effective and safe treatment for malignant brain edema.

Key words:Vascular endothelial growth factors,Brain edema,Brain neoplasms,Bevacizumab